SEC Tracker
Get the app

Seres Therapeutics MCRB

Seres Therapeutics: signs a material agreement, ends a material agreement and 3 other items

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Ends a material agreement (1.02)
  • Completes an acquisition or sale of assets (2.01)
  • Sells unregistered shares (3.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Seres Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
  2. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
  3. Volitionrx VNRX public float $73M, Jun 30, 2025
  4. Macrogenics MGNX public float $74M, Jun 30, 2025
  5. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025